N1-(2-(6H-indolo[2,3-b]quinoxalin-6-yl)ethyl)-N2,N2-dimethylethane-1,2-diamine

ID: ALA4092501

PubChem CID: 137653465

Max Phase: Preclinical

Molecular Formula: C20H23N5

Molecular Weight: 333.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCNCCn1c2ccccc2c2nc3ccccc3nc21

Standard InChI:  InChI=1S/C20H23N5/c1-24(2)13-11-21-12-14-25-18-10-6-3-7-15(18)19-20(25)23-17-9-5-4-8-16(17)22-19/h3-10,21H,11-14H2,1-2H3

Standard InChI Key:  PEKKLDGFPWCPEY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.8612  -17.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8600  -18.6904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5681  -19.0994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5663  -17.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2749  -17.8673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2757  -18.6863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9842  -19.0933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9786  -17.4570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6877  -17.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6954  -18.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4767  -18.9254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4644  -17.6001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9498  -18.2584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7607  -18.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0872  -17.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5967  -16.7582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7875  -16.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7372  -19.6999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5383  -19.8616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7988  -20.6361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5998  -20.7978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8603  -21.5723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6614  -21.7340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9219  -22.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2019  -21.1211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 13  1  0
 12  9  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4092501

    ---

Associated Targets(non-human)

CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 333.44Molecular Weight (Monoisotopic): 333.1953AlogP: 2.89#Rotatable Bonds: 6
Polar Surface Area: 45.98Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.85CX LogP: 3.05CX LogD: 0.64
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -1.25

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source